Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 1,564,000 | $56,945,240 | -4% | 0.7% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,312,550 | $47,789,946 | -6% | 0.02% |
| 3. | Renaissance Technologies Jim Simons | 1,195,371 | $43,523,458 | +11% | 0.06% |
| 4. | AQR Capital Management Cliff Asness | 934,326 | $34,018,811 | +31% | 0.01% |
| 5. | Royce & Associates Chuck Royce | 362,464 | $13,197,314 | +2% | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | $8,147,424.00 | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | $134,524.60 | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | $28,146.60 | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | $3,180,072.00 | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | $104,855.10 | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.05 | 35,852 | $1,543,589.93 | 13,115 | 2026-09-18 | Filing | |
| $43.00 | 800 | $34,400.00 | 13,115 | 2026-09-17 | Filing | |
| $43.01 | 1,800 | $77,426.28 | 13,115 | 2026-09-16 | Filing | |
| $43.10 | 22,954 | $989,349.54 | 13,115 | 2026-09-08 | Filing | |
| $42.79 | 1,000 | $42,794.70 | 13,115 | 2026-09-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 82,530 | $3,240,128 | 0.06% | |
| 2. | 42,170 | $1,655,594 | 0.05% | |
| 3. | 21,006 | $831,838 | 0% | |
| 4. | 16,468 | $646,534 | 0.02% | |
| 5. | 9,182 | $360,485 | 0.28% |
News See All
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?
Is HRMY a good stock to buy? We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on r/StockPickNews by EaseQuiet529. In this article, we will summarize the bulls’ thesis on HRMY.
10 Best Stocks to Buy Right Now According to AI
In this article, we discuss the 10 Best Stocks to Buy Right Now According to AI.
Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best healthcare stocks to buy for the long term. Harmony Biosciences Holdings, Inc.
10 Best Healthcare Stocks to Buy for the Long Term
In this article, we will look at the 10 Best Healthcare Stocks to Buy for the Long Term.
10 Best Small-Cap Value Stocks to Buy
In this article, we will look at the 10 Best Small-Cap Value Stocks to Buy.
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best cheap biotech stocks to buy now. On February 25, Deutsche Bank adjusted the price target on Harmony Biosciences Holdings, Inc.
12 Cheap Biotech Stocks to Buy Now
In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now. On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is among the 20 Best Investments in 2026. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best investment stocks on our list.
20 Best Investments in 2026
In this article, we will be talking about the 20 Best Investments in 2026. The S&P 500 reached a new high as investors focused on upcoming tech sector earnings, and U.S.
Hedge Fund Resource Center